Biotech | April 06, 2022
MilliporeSigma acquires MAST platform from Lonza
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
The partnership demonstrates increasing adoption of tetra data to create unrestricted innovation
The new facility is scheduled to start operation in the first half of 2024
New high-throughput, no-wash assays contribute to the development, manufacture and quality control of safer, more effective biotherapeutics
The investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines
Bayer will be setting up 27 telemedicine centres in 12 districts across 8 states with implementing partners Telerad RxDx and Piramal Swasthya
The plant is scheduled to come on stream in September 2024
The funding will accelerate the AI-driven healthcare company's market expansion into the global market and support new product development
The fund will take equity positions in India-focused healthcare and life sciences-related companies
The company’s differentiated value proposition comes during a time of unprecedented disruption in the life science supply chain
Subscribe To Our Newsletter & Stay Updated
